HIV-1 protease-IN-4
HIV-1 protease-IN-4 (Compound II-22) is a prodrug of atazanavir designed to significantly improve its pharmacokinetic profile. In vivo rat studies demonstrate it enhances atazanavir bioavailability, increasing AUC by 5-fold and C24 by 67-fold compared to atazanavir alone, making it a valuable tool for antiviral and prodrug delivery research.
Product Specifications
Field of Research
Infectious Disease & Virology, Protein Biochemistry
Molecular Formula
C48H69N7O11
Molecular Weight
920.1
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog